ALOX15, arachidonate 15-lipoxygenase, 246

N. diseases: 205; N. variants: 5
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0027627
Disease: Neoplasm Metastasis
Neoplasm Metastasis
0.100 Biomarker phenotype BEFREE Previously, we demonstrated that a 12-lipoxygenase (12-LOX) metabolite of arachidonic acid, 12(S)-hydroxyeicosatetraenoic acid, enhances the invasiveness of prostate cancer cells and that a 12-LOX-selective inhibitor [N-benzyl-N-hydroxy-5-phenylpentanamide] reduces experimental metastasis in animal model systems. 7624992 1995
CUI: C0376358
Disease: Malignant neoplasm of prostate
Malignant neoplasm of prostate
0.100 AlteredExpression disease BEFREE 12-LOX mRNA levels were elevated in cancer cells and the expression associated with poor differentiation and invasiveness of prostate cancer. 7624992 1995
CUI: C0600139
Disease: Prostate carcinoma
Prostate carcinoma
0.100 AlteredExpression disease BEFREE 12-LOX mRNA levels were elevated in cancer cells and the expression associated with poor differentiation and invasiveness of prostate cancer. 7624992 1995
CUI: C0001418
Disease: Adenocarcinoma
Adenocarcinoma
0.030 AlteredExpression group BEFREE A statistically significantly greater number of cases were found to have an elevated level of 12-LOX among T3, high grade, and surgical margin-positive than T2, intermediate, and low grade, and surgical margin-negative prostatic adenocarcinomas. 7624992 1995
CUI: C0017658
Disease: Glomerulonephritis
Glomerulonephritis
0.200 Biomarker disease RGD Co-regulated expression of glomerular 12/15-lipoxygenase and interleukin-4 mRNAs in rat nephrotoxic nephritis. 7967345 1994
CUI: C0027697
Disease: Nephritis
Nephritis
0.010 AlteredExpression disease BEFREE Co-regulated expression of glomerular 12/15-lipoxygenase and interleukin-4 mRNAs in rat nephrotoxic nephritis. 7967345 1994
CUI: C0006142
Disease: Malignant neoplasm of breast
Malignant neoplasm of breast
0.020 Biomarker disease BEFREE The estrogen-dependent, linoleic acid (LA)-unresponsive, MCF-7 breast cancer cell line was transfected with 12-lipoxygenase (12-LOX) cDNA (MCF-7/12-LOX cells). 9020925 1996
CUI: C0678222
Disease: Breast Carcinoma
Breast Carcinoma
0.020 Biomarker disease BEFREE The estrogen-dependent, linoleic acid (LA)-unresponsive, MCF-7 breast cancer cell line was transfected with 12-lipoxygenase (12-LOX) cDNA (MCF-7/12-LOX cells). 9020925 1996
CUI: C0007137
Disease: Squamous cell carcinoma
Squamous cell carcinoma
0.010 AlteredExpression disease BEFREE We studied the dependency of basal 12-lipoxygenase (12-LOX; arachidonate:oxygen 12-oxidoreductase, EC 1.13.11.31) expression and activity on functional protein tyrosine kinase of the epidermal growth factor receptor (EGF-R) and on 12-LOX activity in human A431 epidermoid carcinoma cells. 9174106 1997
CUI: C0376358
Disease: Malignant neoplasm of prostate
Malignant neoplasm of prostate
0.100 AlteredExpression disease BEFREE When we analyzed the relationship between DCC loss of expression and 12-LOX elevation in prostate cancer pati 9321930 1997
CUI: C0600139
Disease: Prostate carcinoma
Prostate carcinoma
0.100 AlteredExpression disease BEFREE When we analyzed the relationship between DCC loss of expression and 12-LOX elevation in prostate cancer pati 9321930 1997
CUI: C0009402
Disease: Colorectal Carcinoma
Colorectal Carcinoma
0.100 AlteredExpression disease BEFREE These results suggest that 15-Lox-1 is highly expressed in human colorectal cancer epithelial cells and that its expression may have a role in colorectal carcinogenesis. 9927047 1999
CUI: C0027651
Disease: Neoplasms
Neoplasms
0.100 Biomarker group BEFREE Eighteen of the 21 were found to have 15-Lox-1 in both tumor tissue and matched adjacent normal tissue, with the 15-Lox-1 expression being significantly higher in most of the tumor tissue. 9927047 1999
CUI: C0596263
Disease: Carcinogenesis
Carcinogenesis
0.100 AlteredExpression phenotype BEFREE These results suggest that 15-Lox-1 is highly expressed in human colorectal cancer epithelial cells and that its expression may have a role in colorectal carcinogenesis. 9927047 1999
Malignant neoplasm of colon and/or rectum
0.080 AlteredExpression disease BEFREE These results suggest that 15-Lox-1 is highly expressed in human colorectal cancer epithelial cells and that its expression may have a role in colorectal carcinogenesis. 9927047 1999
CUI: C0009404
Disease: Colorectal Neoplasms
Colorectal Neoplasms
0.020 Biomarker group BEFREE Immunohistochemical studies showed 15-Lox-1 localization in the glandular epithelium of human colorectal tumor tissue. 9927047 1999
CUI: C0003873
Disease: Rheumatoid Arthritis
Rheumatoid Arthritis
0.030 AlteredExpression disease BEFREE RT-PCR results showed that human RA type B synoviocytes expressed a reticulocyte-type 15-LOX. 10332966 1999
CUI: C0027651
Disease: Neoplasms
Neoplasms
0.100 AlteredExpression group BEFREE Comparison of the expression of 12-LOX in skin primary tumors and its lung metastases indicated a stable expression. 10667390 1999
CUI: C0025202
Disease: melanoma
melanoma
0.030 AlteredExpression disease BEFREE 15% of the cell population), human melanoma lines (HT168, M1, HT199, HT18 and WM35) express the platelet-type isoform of 12-LOX both at mRNA and protein levels. 10667390 1999
CUI: C0037286
Disease: Skin Neoplasms
Skin Neoplasms
0.020 AlteredExpression group BEFREE 12-LOX expression was demonstrated in cultured tumor cells and in skin tumor xenografts. 10667390 1999
Secondary malignant neoplasm of lung
0.010 AlteredExpression disease BEFREE Comparison of the expression of 12-LOX in skin primary tumors and its lung metastases indicated a stable expression. 10667390 1999
CUI: C0001418
Disease: Adenocarcinoma
Adenocarcinoma
0.030 AlteredExpression group LHGDN Concordant induction of 15-lipoxygenase-1 and mutant p53 expression in human prostate adenocarcinoma: correlation with Gleason staging. 11023533 2000
CUI: C0014859
Disease: Esophageal Neoplasms
Esophageal Neoplasms
0.310 AlteredExpression group BEFREE These findings demonstrate that 15-LOX-1 is down-regulated in human esophageal carcinomas and that NSAIDs induce apoptosis in esophageal cancer cells via up-regulation of 15-LOX-1. 11406566 2001
CUI: C0014859
Disease: Esophageal Neoplasms
Esophageal Neoplasms
0.310 Biomarker group CTD_human These findings demonstrate that 15-LOX-1 is down-regulated in human esophageal carcinomas and that NSAIDs induce apoptosis in esophageal cancer cells via up-regulation of 15-LOX-1. 11406566 2001
CUI: C0546837
Disease: Malignant neoplasm of esophagus
Malignant neoplasm of esophagus
0.310 Biomarker disease CTD_human These findings demonstrate that 15-LOX-1 is down-regulated in human esophageal carcinomas and that NSAIDs induce apoptosis in esophageal cancer cells via up-regulation of 15-LOX-1. 11406566 2001